Office of Regulatory Affairs

INSTITUTIONAL REVIEW BOARD (IRB)

• IRB Home
• IRB Updates
• IRB 101
• eRIC (Electronic IRB Submission System
  
  
• IRB Board Members
• Calendar of meetings
• IRB Education Workshop
  
• IRB Manuals
• MedStar Health Research Institute-Georgetown University Oncology IRB
• Social & Behavioral IRB
• Student-conducted Research
• GHUCCTS IRB


• IRB Forms
• Radiation Safety Forms
• HIPAA Regulations
• Human Subject Protection Training
• HIPAA Training
• Report Research Compliance Complaint or Concern
• IRB Fees
• Federal Wide Assurance (FWA)
• FDA Information Sheet Guidance for IRBs, Clinical Investigators, and Sponsors
  
• Qatar Supreme Council of Health Guidelines, Regulations and Policies For Research Involving Human Subjects [A4] [Letter]
• Protection of Minors Policy


• Contact Info

Please see the new Protection of Minor Policy

General Information

eRIC URL is https://eric.georgetown.edu

On behalf of Georgetown University, the Institutional Review Board's (IRB) major role is to safeguard the rights and welfare of all human subjects who participate in research projects conducted by Georgetown. In compliance with Federal law and institutional policy, all research projects involving human subjects or human material must be reviewed and approved by the IRB. All biomedical, social and behavioral research projects conducted by the faculty, the staff and students of the University are subject to the Policies and Procedures of the Institutional Review Board.

The Georgetown University IRB has the authority to disapprove, modify, or approve protocols based upon consideration of human subject protection. It also requires progress reports from the investigators at least annually and oversees the conduct of the study.

The overall criteria for IRB approval are:

1. The risks to subjects are minimized as much as possible.
2. The risks to subjects are reasonable in relation to anticipated benefits.
3. The informed consent is adequate.
4. Where appropriate, the research plan makes provisions for the safety of the subjects during the data collection process.
5. Where appropriate, there are adequate provisions to protect the privacy of subjects and maintain confidentiality of data.
6. Appropriate safeguards are included within the study to protect the rights and welfare of the vulnerable subjects.

Quick Links:

• Clinical Trials Office
• University Counsel
• HIPAA Information for Researchers
• Georgetown University Financial Conflicts of Interest Policy
• Lombardi Comprehensive Cancer Center
• Office of Compliance and Ethics
• Registration of Clinical Trials